Columnist Betty Vertin hopes her family's experience with kidney stones might help you be better prepared while living with DMD.
The FDA has given the green light to a clinical trial testing ATA-200, a gene therapy for limb-girdle muscular dystrophy ...
Despite positive trial data, Sarepta Therapeutics has decided to stop the clinical development of SRP-5051 (vesleteplirsen), an exon 51-skipping therapy for some people with Duchenne muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback